Human stem cell therapy in ischaemic stroke: a review

Area of Science:

• Regenerative Medicine
• Neurology
• Vascular Biology

Background:

• Stroke is a major cause of death and disability, with 15 million cases annually and significant unmet treatment needs.
• Existing stroke therapies provide limited benefits, highlighting the urgent requirement for innovative treatment strategies.
• Stem cell therapy, successful in hematological diseases, is being investigated for neurological and vascular conditions.

Purpose of the Study:

• To review the scientific basis of stem cell therapy for ischemic stroke.
• To discuss preclinical findings and early-stage clinical trial evidence.
• To explore the potential of stem cells in improving functional outcomes post-stroke.

Main Methods:

• Review of preclinical animal models of ischemic stroke.
• Analysis of current clinical trial data on stem cell therapy for stroke.
• Synthesis of scientific literature on stem cell mechanisms and applications in stroke.

Main Results:

• Animal models demonstrate significant functional recovery with stem cell interventions.
• Early clinical trials are exploring the safety and efficacy of stem cell treatments.
• Evidence suggests potential for stem cells to promote neuroprotection and repair.

Conclusions:

• Stem cell therapy presents a promising avenue for novel ischemic stroke treatments.
• Further clinical research is essential to translate preclinical success to patient care.
• Advancing stem cell therapy could significantly improve outcomes for stroke survivors.